GB201511158D0 - Cell modification and application in therapy - Google Patents

Cell modification and application in therapy

Info

Publication number
GB201511158D0
GB201511158D0 GBGB1511158.6A GB201511158A GB201511158D0 GB 201511158 D0 GB201511158 D0 GB 201511158D0 GB 201511158 A GB201511158 A GB 201511158A GB 201511158 D0 GB201511158 D0 GB 201511158D0
Authority
GB
United Kingdom
Prior art keywords
therapy
application
cell modification
modification
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1511158.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GBGB1511158.6A priority Critical patent/GB201511158D0/en
Publication of GB201511158D0 publication Critical patent/GB201511158D0/en
Priority to PCT/GB2016/051881 priority patent/WO2016207637A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1511158.6A 2015-06-24 2015-06-24 Cell modification and application in therapy Ceased GB201511158D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1511158.6A GB201511158D0 (en) 2015-06-24 2015-06-24 Cell modification and application in therapy
PCT/GB2016/051881 WO2016207637A1 (en) 2015-06-24 2016-06-23 Cell modification and application in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1511158.6A GB201511158D0 (en) 2015-06-24 2015-06-24 Cell modification and application in therapy

Publications (1)

Publication Number Publication Date
GB201511158D0 true GB201511158D0 (en) 2015-08-05

Family

ID=53784476

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1511158.6A Ceased GB201511158D0 (en) 2015-06-24 2015-06-24 Cell modification and application in therapy

Country Status (2)

Country Link
GB (1) GB201511158D0 (en)
WO (1) WO2016207637A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1984399A4 (en) * 2006-02-10 2010-03-03 Univ California Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps
GB201322396D0 (en) * 2013-12-18 2014-02-05 Univ Nottingham Transduction

Also Published As

Publication number Publication date
WO2016207637A1 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
HK1256380A1 (en) Modified cells and methods of therapy
HK1250741A1 (en) Modified gamma delta cells and uses thereof
IL258666A (en) Natural killer cells and ilc3 cells and uses thereof
RS62047B1 (en) Immunosuppressive agents and their use in therapy
GB201511382D0 (en) Novel compounds and their use in therapy
GB201510758D0 (en) Novel TNFa structure for use in therapy
IL259202A (en) Modified immune cells and uses thereof
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
PL3325478T3 (en) New therapeutic compound and use in therapy
GB201600747D0 (en) Improvements in and relating to devices
EP3143036C0 (en) Par-1 based therapeutic conjugates and uses thereof
GB201514431D0 (en) Improvements in and relating to materials
GB201304038D0 (en) Treated cells and therapeutic uses
GB201308753D0 (en) Compounds and their use in therapy
GB201521209D0 (en) Title and application in german
GB201511158D0 (en) Cell modification and application in therapy
GB201506451D0 (en) Improvements in and relating to devices
GB201513286D0 (en) Improvements in and relating to construction
GB201506463D0 (en) Improvements in and relating to polymer materials - II
GB201506453D0 (en) Improvements in and relating to polymer materials - I
GB2530075B (en) Improvements in and relating to eyewashing
GB201409978D0 (en) Novel compounds and their use in therapy
GB201504773D0 (en) Methods and devices used in roofing
GB201502767D0 (en) Energy reduction in buildings and transport
GB201423338D0 (en) Slowing aging cell and body RNA

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)